{"nct_id":"NCT04250337","title":"Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2020-02-03","start_date_type":"ACTUAL","primary_completion_date":"2021-08-11","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}